Prolactin release is enhanced in proportion to excess visceral fat in obese women

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 9, 2004, Pages 4445-4449

  Kok, Petra ^a   Roelfsema, Ferdinand ^a   Frölich, Marijke ^a   Meinders, A Edo ^a   Pijl, Hanno ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; PROLACTIN;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LEAN BODY WEIGHT; MENSTRUAL CYCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; SUBCUTANEOUS FAT; VISCERA;

ADIPOSE TISSUE; ADULT; BODY MASS INDEX; FEMALE; HUMANS; OBESITY; PROLACTIN; RECEPTORS, DOPAMINE D2; VISCERA;

ANIMALIA;

EID: 4544294984     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032184     Document Type: Article

References (32)

1. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225-268
2. Freemark M, Fleenor D, Driscoll P, Binart N, Kelly P 2001 Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 142:532-537
3. Ben Jonathan N, Hnasko R 2001 Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22:724-763
4. Pijl H 2003 Reduced dopaminergic tone in hypothalamic neural circuits: expression of a "thrifty" genotype underlying the metabolic syndrome? Eur J Pharmacol 480:125-31
5. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS 2001 Brain dopamine and obesity. Lancet 357:354-357
6. Blake GM, Fogelman I 1997 Technical principles of dual energy x-ray absorptiometry. Semin Nucl Med 27:210-228
7. Langendonk JG, Pijl H, Toornvliet AC, Burggraaf J, Frolich M, Schoemaker RC, Doornbos J, Cohen AF, Meinders AE 1998 Circadian rhythm of plasma leptin levels in upper and lower body obese women: influence of body fat distribution and weight loss. J Clin Endocrinol Metab 83:1706-1712
8. Veldhuis JD, Johnson ML 1986 Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol 250:E486-E493
9. Johnson ML, Veldhuis JD 1995 Evolution of deconvolution analysis as a hormone pulse detection period. Methods Neurosci 28:1-24
10. Sievertsen GD, Lim VS, Nakawatase C, Frohman LA 1980 Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure. J Clin Endocrinol Metab 50:846-852
11. Pincus SM, Keefe DL 1992 Quantification of hormone pulsatility via an approximate entropy algorithm. Am J Physiol 262:E741-E754
12. Groote VR, van den BG, Pincus SM, Frolich M, Veldhuis JD, Roelfsema F 1999 Increased episodic release and disorderliness of prolactin secretion in both micro- and macroprolactinomas. Eur J Endocrinol 140:192-200
13. Veldhuis JD, Pincus SM 1998 Orderliness of hormone release patterns: a complementary measure to conventional pulsatile and circadian analyses. Eur J Endocrinol 138:358-362
14. Bernini GP, Lucarini AR, Vivaldi MS, Del Corso C, Lenzi M, Salvetti A 1989 Naloxone does not antagonize the antihypertensive effect of chronic captopril therapy in hypertensive patients. Cardiovasc Drugs Ther 3:829-833
15. Kopelman PG, White N, Pilkington TR, Jeffcoate SL 1979 Impaired hypothalamic control of prolactin secretion in massive obesity. Lancet 1:747-750
16. Rojdmark S, Berg A, Rossner S, Wetterberg L 1991 Nocturnal melatonin secretion in thyroid disease and in obesity. Clin Endocrinol (Oxf) 35:61-65
17. Rojdmark S, Rossner S 1991 Decreased dopaminergic control of prolactin secretion in male obesity: normalization by fasting. Metabolism 40:191-195
18. Weaver JU, Noonan K, Kopelman PG 1991 An association between hypothalamic-pituitary dysfunction and peripheral endocrine function in extreme obesity. Clin Endocrinol (Oxf) 35:97-102
19. Papalia D, Lunetta M, Di Mauro M 1989 Effects of naloxone on prolactin, growth hormone and cortisol response to insulin hypoglycemia in obese subjects. J Endocrinol Invest 12:777-782
20. Bernini GP, Argenio GF, Vivaldi MS, Del Corso C, Sgro M, Franchi F, Luisi M 1989 Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotoninergic system. Horm Res 31:133-137
21. Altomonte L, Zoli A, Alessi F, Ghirlanda G, Manna R, Greco AV 1987 Effect of fenfluramine on growth hormone and prolactin secretion in obese subjects. Horm Res 27:190-194
22. Amatruda JM, Hochstein M, Hsu TH, Lockwood DH 1982 Hypothalamic and pituitary dysfunction in obese males. Int J Obes 6:183-189
23. Cavagnini F, Maraschini C, Pinto M, Dubini A, Polli EE 1981 Impaired prolactin secretion in obese patients. J Endocrinol Invest 4:149-153
24. Copinschi G, De Laet MH, Brion JP, Leclercq R, L'Hermite M, Robyn C, Virasoro E, Van Cauter E 1978 Simultaneous study of Cortisol, growth hormone and prolactin nyctohemeral variations in normal and obese subjects. Influence of prolonged fasting in obesity. Clin Endocrinol (Oxf) 9:15-26
25. Doknic M, Pekic S, Zarkovic M, Medic-Stojanoska M, Dieguez C, Casanueva F, Popovic V 2002 Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. Eur J Endocrinol 147:77-84
26. Greenman Y, Tordjman K, Stern N 1998 Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clin Endocrinol (Oxf) 48:547-553
27. Casey DE 1996 Side effect profiles of new antipsychotic agents. J Clin Psychiatry 57:40-45
28. Hummer M, Kemmler G, Kurz M, Kurzthaler I, Oberbauer H, Fleischhacker WW 1995 Weight gain induced by clozapine. Eur Neuropsychopharmacol 5:437-440
29. Baptista T, Alastre T, Contreras Q, Martinez JL, Araujo de Baptista E, Paez X, Hernandez L 1997 Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy men: relationship with body weight regulation. Pharmacopsychiatry 30:250-255
30. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295
31. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161
32. Watanobe H, Suda T, Wikberg JE, Schioth HB 1999 Evidence that physiological levels of circulating leptin exert a stimulatory effect on luteinizing hormone and prolactin surges in rats. Biochem Biophys Res Commun 263:162-165